SEC Form 4 · accession 0000899243-18-000764
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bob D Brown
Officer — Chief Scientific Officer
Period of report
Jan 4, 2018
Accepted (ET)
Jan 8, 2018 · 9:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $9.30 | Jan 4, 2018 | A | 105,000 | A | — | Jan 4, 2028 | Common Stock | 105,000 | 105,000 | D |
Explanation of responses
- F1The option vests in 48 monthly installments over the four-year period starting on the last day of January 2018, subject in each case to the reporting person's continued service with the issuer through the applicable vesting date.